BNTC
Benitec Biopharma Ltd
9.00$
-6.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -200.0% | – | – | – | – | -100.0% | – | – | – | – | |
| – | – | -400.0% | – | +506.7% | -11.0% | +30.9% | +162.3% | -57.6% | +1.7% | -0.8% | +4.2% | – | |
| – | -100.9% | – | -800.0% | – | – | – | – | -142.4% | – | – | – | – | |
| – | +15.2% | -49.7% | +36.9% | +2.1% | +50.2% | +20.6% | -43.1% | -8.8% | +73.1% | +8.0% | +52.7% | – | |
| – | +17.6% | -13.5% | +29.0% | +8.3% | +145.7% | +63.1% | +52.5% | -52.3% | +17.3% | -3.4% | -10.2% | – | |
| – | +15.8% | -40.2% | +33.9% | +4.4% | +86.6% | +41.9% | +12.0% | -43.8% | +37.4% | +1.6% | +6.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -33.3% | – | – | +36.3% | +0.0% | +25.9% | -2.4% | +37.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.